NCT03886181 2025-12-08
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)
Alpha Tau Medical LTD.
Phase NA Terminated
Clinical Trials
20 trialsNCT04272034 2025-10-16
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors
Incyte Corporation
Phase 1 Terminated
NCT05110924 2024-12-17
BASINEL
University Hospital, Ghent
Phase NA Terminated
NCT04308395 2024-09-24
Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)
Sol-Gel Technologies, Ltd.
Phase 3 Terminated
NCT03370861 2024-09-05
MINING
Washington University School of Medicine
Terminated
NCT03646188 2024-03-12
Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC)
SkinJect, Inc.
Phase 1 Terminated
NCT04410874 2024-03-07
MUSIC-01
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase 1/2 Terminated
NCT04688749 2023-07-25
DermaSense
Aristotle University Of Thessaloniki
Terminated
NCT04155190 2023-05-31
An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC
Sol-Gel Technologies, Ltd.
Phase 2 Terminated
NCT02956889 2020-01-29
virgilio
Istituto Clinico Humanitas
Phase 2 Terminated
NCT03420846 2020-01-28
Efficiency of Presurgical Basal Cell Carcinoma Margin Mapping
Michelson Diagnostics Ltd.
Phase NA Terminated
NCT03321903 2019-12-19
EPR Tumor Oximetry With CE India Ink
Dartmouth-Hitchcock Medical Center
Terminated
NCT02067104 2019-08-14
Vismodegib in Basal Cell Carcinomas (BCC) Chemoprevention
University of Arizona
Phase 2 Terminated
NCT02303041 2019-01-29
Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma
Stanford University
Phase 2 Terminated
NCT01604252 2017-07-28
An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)
Genentech, Inc.
Terminated
NCT01898598 2017-05-08
A Study of Vismodegib With Surgery in Participants With Previously Untreated Basal Cell Carcinoma
Hoffmann-La Roche
Phase 2 Terminated
NCT00663910 2017-01-02
Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer
The Cleveland Clinic
Phase EARLY_PHASE1 Terminated
NCT01033019 2015-10-30
To Evaluate the Safety, Local Tolerability, PK and PD of LDE225 on Sporadic Superficial and Nodular Skin Basal Cell Carcinomas (sBCC)
Novartis
Phase 2 Terminated
NCT00023790 2011-08-24
Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin
Case Comprehensive Cancer Center
Phase 1 Terminated
NCT00049959 2011-03-16
Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.
QLT Inc.
Phase 3 Terminated